You are here

Merck & Co., Inc.

Member Since 2015

Kenneth C. Frazier

Chairman of the Board and Chief Executive Officer

Kenneth C. Frazier is chairman of the board and chief executive officer of Merck & Co., Inc.

Previously, Ken served as president of Merck with responsibility for the company’s three major divisions: Global Human Health, Merck’s sales and marketing division for pharmaceutical and vaccine products; Merck Manufacturing Division, Merck’s manufacturing and supply division; and Merck Research Laboratories, Merck’s research organization.

Ken has held a broad range of senior management positions since joining Merck in 1992 as vice president, general counsel and secretary of the Astra Merck Group. He was elected vice president of Public Affairs in 1994, and, in 1997, assumed the additional responsibilities of assistant general counsel, corporate staff. Ken was promoted to vice president and deputy general counsel in January 1999. In December 1999, he became senior vice president and general counsel. In this role, he oversaw Merck’s legal and public affairs functions and the Merck Foundation. In November 2006, he was promoted to executive vice president and general counsel. Ken served as executive vice president and president, Global Human Health, from 2007 to May 2010, when he became Merck president. Ken became CEO and member of the board of directors January 1, 2011, and became chairman of the board on December 1, 2011.

Prior to joining Merck, Ken was a partner with the Philadelphia law firm of Drinker Biddle & Reath. Ken sits on the boards of PhRMA, Weill Cornell Medicine, Exxon Mobil Corporation and Cornerstone Christian Academy in Philadelphia, PA. He also is a member of the American Academy of Arts and Sciences, the President’s Export Council, The Business Council, the Council of the American Law Institute and the American Bar Association.

Ken received his bachelor’s degree from The Pennsylvania State University and holds a J.D. from Harvard Law School.

CEO Cancer Gold Standard™

Gold Standard  Employer

Since 2018


Merck is at the forefront of cancer research, with inventions that are helping to transform prevention and treatment of the disease. However, our commitment to tackling cancer extends beyond our scientific research. At Merck, our employees are our most critical resource, which is why we’re pleased to be recognized with The Gold Standard. When our employees feel their best, they can be and do their best, which is crucial to helping us achieve our mission of improving and saving lives.

— Kenneth C. Frazier

Gold Standard  Task Force Participation

Task Force Member(s): Virgina Peddicord, Director

Life Sciences Consortium

LSC  Task Force Participation

Task Force Leadership: Kald Abdallah, MD, PhD, AVP, US Oncology Global Medical Affairs & Leader, Oncology Global Medical Affairs

Task Force Member(s): Roy D. Baynes, MD, PhD, Senior Vice President & Head of Global Clinical Development, Chief Medical Officer; Eric Rudin, MD, Vice President and Therapeutic Area Head

Merck & Co., Inc.

We are a global healthcare company with a 125-year history of working to make a difference. To make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.